login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SORRENTO THERAPEUTICS INC (SRNE) Stock News
USA
- NASDAQ:SRNE -
US83587F2020
-
Common Stock
0.3073
USD
-0.08 (-20.26%)
Last: 2/22/2023, 8:27:19 PM
0.2801
USD
-0.03 (-8.85%)
After Hours:
2/22/2023, 8:27:19 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SRNE Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Sorrento Therapeutics, Inc.
Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the
3 years ago - By: The Motley Fool
- Mentions:
SCLX
Why Shares of Scilex Slumped This Week
3 years ago - By: Benzinga
- Mentions:
INFI
TNDM
APRE
CMPS
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
3 years ago - By: The Motley Fool
Why Sorrento Therapeutics Stock Crashed Today
3 years ago - By: Benzinga
- Mentions:
CERE
HOTH
TRTX
RELI
...
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
3 years ago - By: Sorrento Therapeutics, Inc.
- Mentions:
SCLX
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case
3 years ago - By: InvestorPlace
- Mentions:
META
GOOG
BBBY
JFBR
Meta Platforms Layoffs 2023: Are More Facebook Job Cuts Coming?
3 years ago - By: InvestorPlace
- Mentions:
GOOG
JFBR
STLA
Alphabet Layoffs 2023: What to Know About the Latest Google Job Cuts
3 years ago - By: InvestorPlace
- Mentions:
BBBY
The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today
3 years ago - By: InvestorPlace
- Mentions:
LLAP
CYRN
WINT
PET
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
3 years ago - By: Seeking Alpha
Sorrento Therapeutics surges 28% as court nods for a $75M loan
3 years ago - By: Sorrento Therapeutics, Inc.
Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)
3 years ago - By: Sorrento Therapeutics, Inc.
Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)
3 years ago - By: Sorrento Therapeutics, Inc.
- Mentions:
SCLX
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
3 years ago - By: Sorrento Therapeutics, Inc.; Scilex Holding Company
Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.
3 years ago - By: InvestorPlace
- Mentions:
BLK
STT
RILY
5 Investors Betting Big on Sorrento Therapeutics (SRNE) Stock
3 years ago - By: Seeking Alpha
- Mentions:
TDC
FSLY
BAC
TWLO
Hot Stocks: TDC climbs on earnings; FSLY upgrade; TWLO restructuring; SRNE bankruptcy
Please enable JavaScript to continue using this application.